Evidence map›Paper›PMID 37105524›Full record

ArticleAnnals of coloproctology2024

Public effect of the 2022 Colorectal Cancer Awareness Campaign delivered through a metaverse platform.

Tae-Gyun Lee, Gil-Hyeon Song, Hong-Min Ahn, Heung-Kwon Oh, Moonkyoung Byun, Eon Chul Han, Sohyun Kim, Chang Woo Kim, Hye Jin Kim, Samin Hong and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Annals of coloproctology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Tae-Gyun LeeDepartment of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Gil-Hyeon SongDepartment of Medicine, Seoul National University College of Medicine, Seoul, Korea.
Hong-Min AhnDepartment of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Heung-Kwon OhDepartment of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Moonkyoung ByunDepartment of Applied Artificial Intelligence, Sungkyunkwan University, Seoul, Korea.
Eon Chul HanColorectal Division of General Surgery, Dongnam Institute of Radiological and Medical Sciences, Busan, Korea.
Sohyun KimDepartment of Surgery, Yeungnam University College of Medicine, Daegu, Korea.
Chang Woo KimDepartment of Colorectal Surgery, Ajou University School of Medicine, Suwon, Korea.
Hye Jin KimColorectal Cancer Center, Kyungpook National University Chilgok Hospital, Daegu, Korea.
Samin Hong365 Hang Surgical Clinic, Seoul, Korea.
Kee-Ho SongSeoul DHU Surgery Clinic, Seoul, Korea.
Chan Wook KimDepartment of Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Yong Beom ChoDepartment of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Funding

Korean Society of Coloproctology
6 · The paper itself

Abstract

purposeThe Korean Society of Coloproctology has been conducting Colorectal Cancer Awareness Campaign, also known as the Gold Ribbon Campaign, every September since 2007. The 2022 campaign was held through a metaverse platform targeting the younger age group under the slogan of raising awareness of early-onset colorectal cancer (CRC). This study aimed to analyze the impact of the 2022 campaign on a metaverse platform.

methodsAnonymized survey data were collected from participants in the metaverse campaign from September 1 to 15, 2022. The satisfaction score of the participants was evaluated by sex, age group, and previous campaign participation status.

resultsDuring the campaign, 2,770 people visited the metaverse. Among them, 455 people participated in the survey (response rate, 16.4%). Approximately 95% of the participants reported being satisfied with the information provided by the campaign, understood the necessity of undergoing screening for and prevention of early-onset CRC, and were familiar with the structure of the metaverse. The satisfaction score for campaign information tended to decrease as the participants' age increased. When the participants' overall level of satisfaction with the metaverse platform was assessed, teenagers scored particularly lower than the other age groups. The satisfaction scores for CRC information provided in the metaverse, as well as the scores for recognizing the seriousness and necessity of screening for early-onset CRC, indicated a high positive tendency (P<0.001).

conclusionMost of the 2022 Gold Ribbon Campaign participants were satisfied with the metaverse platform. Medical society should pay attention to increasing participation in and satisfaction with future public campaigns.

Indexed as

Cancer screeningColorectal neoplasmsEarly detection of cancerHealth campaignsOnline social networks

Identifiers

PMID37105524
PMCPMC11082545

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.